Rutgers Provides Exclusive License for Non-Invasive Cardiovascular Disease Monitoring Sensor Technology to Everist Genomics

News Sources wrote an interesting post today on
Here’s a quick excerpt
Rutgers and Everist Genomics work to detect early-stage disease in asymptomatic patients
(PRWeb November 28, 2012)
Read the full story at

Read the rest of this great post here